Journey Medical Corporation
DERM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 17.5% | 14.2% | -3.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.4% | 60% | 63.5% | 83.6% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -1.8% | -11.4% | -16% | 25.1% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -13.1% | -25.3% | -31% | 11.2% |
| EPS Diluted | -0.09 | -0.16 | -0.18 | 0.069 |
| % Growth | 43.8% | 11.1% | -362% | – |
| Operating Cash Flow | – | -$0 | -$0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$0 | -$0 | $0 |